NDC 72516-024 – Papaverine Hydrochloride
Papaverine Hydrochloride 30 mg/mL · Injection, Solution · Intravenous
Product NDC72516-024
Product details
- Brand name
- Papaverine Hydrochloride
- Generic name
- Papaverine Hydrochloride
- Labeler
- Oryza Pharmaceuticals Inc.
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Marketing category
- UNAPPROVED DRUG OTHER
- Marketed since
- February 1, 2021
- Listing expires
- December 31, 2026
Active ingredients
- Papaverine Hydrochloride 30 mg/mL
Uses, dosage, side effects and warnings for Papaverine Hydrochloride →
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 72516-024-10 | 10 VIAL in 1 CARTON (72516-024-10) / 2 mL in 1 VIAL | Feb 1, 2021 |
| 72516-024-25 | 25 VIAL in 1 CARTON (72516-024-25) / 2 mL in 1 VIAL | Feb 1, 2021 |
Recalls mentioning this NDC
- D-0742-2022 Apr 13, 2022 · Class II
Lack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.